Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 232-452-1 | CAS number: 8031-44-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Sensitisation data (human)
Administrative data
- Endpoint:
- sensitisation data (humans)
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- January 1972 to June 1973
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 975
Materials and methods
- Type of sensitisation studied:
- skin
- Study type:
- study with volunteers
- Principles of method if other than guideline:
- Patch testing with anhydrous lanolin and two preparations of hydrogenated lanolin were applied to the intact skin of 756 patients with contact dermatitis. Every individual showing a positive response more than ++ to any of the material was subjected to two series of further patch tests.
Test material
- Reference substance name:
- Lanolin, hydrogenated
- EC Number:
- 232-452-1
- EC Name:
- Lanolin, hydrogenated
- Cas Number:
- 8031-44-5
- Molecular formula:
- UVCB: not available
- IUPAC Name:
- Lanolin, wool wax, hydrogenated
Constituent 1
Method
- Type of population:
- other: patients
- Ethical approval:
- not specified
- Subjects:
- - Number of subjects exposed: 756
- Clinical history:
- - History of allergy or casuistics for study subject or populations: the subjects were attending the clinic because of contact dermatitis.
- Route of administration:
- dermal
- Details on study design:
- TYPE OF TEST(S) USED: patch test (epicutaneous test)
ADMINISTRATION: the subjects were patch tested with anhydrous lanolin (JP) and two preparations of hydrogenated lanolin (lanocerina extra and Lanol A) that were applied in standard fashion to the grossly intact skin. Every individual who showed a positive response more than ++ to any of the materials was subjected to two series of further patch tests.
Year 1972: patch tests with anhydrous lanolin and hydrogenated lanolin to 502 dermatologic patients.
Year 1973 (January-June): patch tests with the same but ageing anhydrous lanolin and hydrogenated lanolin to 254 additional patients.
January 1972-June 1973: patch tests with betamethasone-17-valerate ointment and the lanocerina extra were carried out in 87 patients with suspected dermatitis from the applied ointment.
Patch tests with a seried of anhydrous lanolin and hydrogenated lanolin preparations supplied by the Takasago Perfumery Co were performed in 24 of the 52 subjects sensitive to anhydrous lanolin JP and/or either or both hydrogenated samples (lanocerina extra and/or lanol A) in January 1972-June 1973 and in the additional 24 subjects from July 1973 to June 1974.
PREPARATION OF TEST MATERIALS:
A. Series of anhydrous lanolin preparations in various stages of modification, supplied by the Takasago Perfumery Co Ltd.
1. Lanolin FC: acid value 1.0-3.0, inferior to lanolin in the JP grade.
2. Lanolin FP: licensed by the Japanese Pharmacopoeia; acid value less than 1.0
3. Lanolin Super: made from lanolin FP by oxidative bleaching
4. Lanolin SP: made from lanolin FP by distillation
5. Lanolin SPM: made from lanolin SP by fractionation with organic solvents.
6. Residue No.19: recovered from the solvents after lanolin SPM is extracted from lanolin SP.
B. Series of hydrogenated lanolin preparations: anhydrous lanolin of the JP grade is completely hydrogenated under a high pressure (200 atm) in the presence of nickel as a catalyst.
1. Lanol A: completely hydrogenated product of lanolin FP
2. Lanol S: made from Lanol A by vapor distillation
3. Lanol 3S: made from Lanol S by molecular distillation
4. Fraction No. 103: initial fraction in the process of molecular distillation of lanol S
5. Lanocerina extra: used in the base of betamethasone-17-valerate ointment and supplied by the Shionogi Pharmaceutical Co.
Results and discussion
- Results of examinations:
- - During patch tests with anhydrous lanolin and hydrogenated lanolin to 502 dermatologic patients (year 1972): 10 (1.99 % incidence) patients showed positive test reactions more than ++ (erythema with oedema) to patch tests with anhydrous lanolin (JP), while 26 (5.18 %) reacted with hydrogenated lanolin (lanocerina extra).
- During patch tests with the same but ageing anhydrous lanolin and hydrogenated lanolin to 254 additional patients (Year 1973 (January-June)): 11 (4.33 %) and 12 (4.72 %) patients were positive to anhydrous lanolin and hydrogenated lanolin respectively.
- During patch tests with betamethasone-17-valerate ointment and the lanocerina extra were carried out in 87 patients with suspected dermatitis from the applied ointment (January 1972-June 1973): 28 showed positive reactions to the ointment and 29 to hydrogenated lanolin. 26 patients showed a positive response to both materials.
- Patch tests with a series of anhydrous lanolin and hydrogenated lanolin preparations supplied by the Takasago Perfumery Co were performed in 24 of the 52 subjects sensitive to anhydrous lanolin JP and/or either or both hydrogenated samples (lanocerina extra and/or lanol A) in January 1972-June 1973 and in the additional 24 subjects from July 1973 to June 1974: the proportion of positive responses more than (++) to each preparation decreased with each stage of purification.
Any other information on results incl. tables
The results of skin reactions to a series of anhydrous lanolin and hydrogenated lanolin are presented in the table below.
Table
Series of anhydrous lanolin preparations | ||||||
Period | Lanolin FC | Lanolin FP | Lanolin Super | Lanolin SP | Lanolin SPM | Residue 19 |
Jan 1972-Jun 1973 | 16/24 (66.7 %) |
13/24 (54.2 %) |
5/24 (20.8 %) |
3/24 (12.5 %) |
0/5 (0.0 %) |
2/5 (40.0 %) |
Jul 1973-Jun 1974 | 14/24 (58.3 %) |
8/24 (33.3 %) |
1/3 (33.3 %) |
3/24 (12.5 % | 2/24 (8.3 %) |
12/24 (50.0 %) |
Total | 30/48 (62.5 %) |
21/48 (43.8 %) |
6/27 (22.2 %) |
6/48 (12.5 %) |
2/29 (6.9 %) |
14/29 (48.3 %) |
Series of hydrogenated lanolin preparations | ||||||
Period | Lanocerina extra |
Lanol A | Lanol S | Lanol 3S | Fraction 103 | |
Jan 1972-Jun 1973 | 18/24 (75.0 %) |
13/24 (54.2 %) |
0/5 (0.0 %) |
0/5 (0.0 %) |
3/5 (60.0 %) |
|
Jul 1973-Jun 1974 | 22/24 (91.7 %) |
15/24 (62.5 %) |
5/24 (20.8 %) |
5/24 (20.8 % |
17/24 (70.8 %) |
|
Total | 40/48 (83.3 %) |
28/48 (58.3 %) |
5.29 (17.2 %) |
5/29 (17.2 %) |
20/29 (69.0 %) |
Applicant's summary and conclusion
- Conclusions:
- The results in 1972 showed that the incidence of sensitivity to hydrogenated lanolin was significantly higher than that to anhydrous lanolin at the 1 % level, while no significant difference was found between both samples in 1973.
- Executive summary:
756 subjects were patch tested with anhydrous lanolin and two preparations of hydrogenated lanolin that were applied to the intact skin of patients with contact dermatitis. Every individual showing a positive response more than ++ to any of the material was subjected to two series of further patch tests.
The results of skin reactions to a series of anhydrous and hydrogenated lanolin preparations in the screened patients revealed that the incidence of skin sensitivity decreased with every stage of purification. The results in 1972 showed that the incidence of sensitivity to hydrogenated lanolin was significantly higher than that to anhydrous lanolin at the 1 % level, while no significant difference was found between both samples in 1973. Contamination by traces of copper, chromium and nickel in hydrogenated preparations is considered, by the study, to be the source of other possible allergens.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.